Bioengineers from the University of California, San Diego have developed a nanosponge cloaked in white blood cells that can absorb inflammatory proteins, a new approach to treatment that may help patients better manage rheumatoid arthritis and ease their suffering.
In episode 2 of ASME TechCast, we explore the communication gap that often exists between engineers and their colleagues, especially clinicians and others in the biomedical industry. We also discuss the new lexicon that members of the Alliance of Advanced Biomedical Engineering (AABME.org) are rolling out to help solve that problem.
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.
Researchers moved closer to solving problems with treating heart disease by developing ways to build tissues and parts of a human heart using human stem cells.
A new “cancer trap,” featuring a protein “bait” and a chemotherapeutic drug lying in wait, promises to catch and kill rogue cancer cells.
Nanoparticles designed with complementary chemical and mechanical forces improve the targeting of tumors with cancer-fighting drugs.
An artificial pancreas that releases both insulin and pramlintide, an analog of amylin, might offer better control during the after-meal period.
Engineers have developed a new process of 3D bioprinting tissues that uses multiple cell-based inks to create more realistic structures in less time than previous methods.
A new device from scientists at McGill University’s Department of Bioengineering allows early and quick detection of life-threatening bacteria.
Cell therapy manufacturing is a new discipline where production of adult and pluripotent stem cell types are required for cell therapies. Several hundreds of clinical trials with adult mesenchymal stem cells for therapies such as auto-immune diseases, bone, cartilage repair and stroke are looking promising. For the pluripotent stem cell therapies, retinal pigment epithelial cells, pancreatic islet progenitors and neurons are being applied for treating blindness, diabetes and Parkinson’s disease in early stage clinical trials.
A low-cost haptic needle simulator aims to train young minds without expensive equipment.
The first viable prototype of an artificial lung offers new hope for the more than one thousand people awaiting lung transplants across the United States.
Barcoded nanoparticles deliver nucleic acids to treat cancer, viral infections, and neurodegenerative diseases.
A new approach to finding drug candidates for fighting cancers can drastically cut the time and money needed to evaluate millions of them.
Surgeons could torch tumors faster and more accurately with help from a new thermal imaging system.